Skip to main content
Equibles
RMTI logo

RMTI · Rockwell Medical, Inc. · Webcasts, Transcripts & Audio

Track RMTI — free

Use RMTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RMTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.00 +0.06 (+0.86%) At close · Oct 26
Rebalance outlook locked
Market Cap
$27.97M
Shares
4.03M
Volume · Oct 26 11.12K Avg daily vol (3M) 26.62K

Rockwell Medical, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Rockwell Medical, Inc. (RMTI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-12
Rockwell Medical, Inc. (RMTI) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-13
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Confident tone Gross Margin Expansion Path Balance Sheet and Cash Flow Customer Wins and Geographic Expansion (West)
Revenue
$17.78M
▲ 10.6% YoY
Gross margin
18.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Rockwell Medical, Inc. (RMTI) Q1 2026 Earnings Call Transcript
Confident tone Financial performance and profitability Pricing actions Customer base and diversification
Revenue
$17.34M
▼ 8.3% YoY
Diluted EPS
$-0.40
Gross margin
16.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Rockwell Medical, Inc. (RMTI) Q4 2025 Earnings Call Transcript
Confident tone 2026 outlook and long-term growth targets Competitive positioning vs. Nipro and Fresenius Customer diversification and concentration risk reduction
Revenue
$18.35M*
▼ 25.6% YoY
Gross margin
21.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Rockwell Medical, Inc. (RMTI) Q3 2025 Earnings Call Transcript
Positive tone largest customer transition adjusted EBITDA profitability cost restructuring and rightsizing
Revenue
$15.93M
▼ 43.8% YoY
Diluted EPS
$-0.50
▼ 225% YoY
Gross margin
14.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Rockwell Medical, Inc. (RMTI) Q2 2025 Earnings Call Transcript
Positive tone 2025 financial guidance Customer transition and largest customer loss Gross margin and operating efficiency
Revenue
$16.07M
▼ 37.8% YoY
Diluted EPS
$-0.50
▼ 600% YoY
Gross margin
15.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Rockwell Medical, Inc. (RMTI) Q1 2025 Earnings Call Transcript
Positive tone Largest customer transition and contract negotiation Financial guidance reiteration Tariff exposure
Revenue
$18.91M
▼ 16.6% YoY
Diluted EPS
$-0.40
Gross margin
16.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Rockwell Medical, Inc. (RMTI) Q4 2024 Earnings Call Transcript
Balanced tone 2024 financial milestones Largest customer transition 2025 financial guidance
Revenue
$24.66M*
▲ 11.6% YoY
Gross margin
14.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript
Positive tone Raised 2024 guidance New agreements (Nipro, at-home partner, Aqua) Largest customer volume decline in 2025
Revenue
$28.32M
▲ 19.1% YoY
Diluted EPS
$0.40
Gross margin
22.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Rockwell Medical, Inc. (RMTI) Q2 2024 Earnings Call Transcript
Confident tone Revenue Growth Gross Margin Expansion Profitability and Cash Flow
Revenue
$25.83M
▲ 42.9% YoY
Diluted EPS
$0.10
Gross margin
17.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Rockwell Medical, Inc. (RMTI) Q1 2024 Earnings Call Transcript
Confident tone Raised 2024 guidance Pricing power and margin expansion New and expanded customer agreements
Revenue
$22.68M
▲ 15.3% YoY
Diluted EPS
$-0.60
Gross margin
13.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-21
Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript
Confident tone Revenue Growth and Guidance Gross Margin Improvement Evoqua Acquisition and Integration
Revenue
$22.09M*
▲ 14.4% YoY
Gross margin
13.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
Rockwell Medical, Inc. (RMTI) Q3 2023 Earnings Call Transcript
Revenue
$23.77M
▲ 27.2% YoY
Diluted EPS
$-0.70
Gross margin
9.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Rockwell Medical, Inc. (RMTI) Q2 2023 Earnings Call Transcript
Revenue
$18.08M
▼ 3.2% YoY
Diluted EPS
$-1.80
Gross margin
5.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Rockwell Medical, Inc. (RMTI) Q1 2023 Earnings Call Transcript
Revenue
$19.67M
▲ 22% YoY
Diluted EPS
$-1.00
Gross margin
13.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-30
Rockwell Medical, Inc. (RMTI) Q4 2022 Earnings Call Transcript
Revenue
$19.31M*
▲ 26% YoY
Gross margin
12.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Rockwell Medical, Inc. (RMTI) Q3 2022 Earnings Call Transcript
Revenue
$18.69M
▲ 16.9% YoY
Diluted EPS
$-2.30
Gross margin
4.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Rockwell Medical, Inc. (RMTI) Q2 2022 Earnings Call Transcript
Revenue
$18.68M
▲ 23.4% YoY
Diluted EPS
$-4.30
Gross margin
9.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Rockwell Medical, Inc. (RMTI) Q1 2022 Earnings Call Transcript
Revenue
$16.12M
▲ 4.2% YoY
Diluted EPS
$-8.40
Gross margin
-4.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-11-15
Rockwell Medical, Inc. (RMTI) Q3 2021 Earnings Call Transcript
Revenue
$15.99M
▲ 4.6% YoY
Diluted EPS
$-8.90
Gross margin
-2.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-16
Rockwell Medical, Inc. (RMTI) Q2 2021 Earnings Call Transcript
Revenue
$15.14M
▼ 4.8% YoY
Diluted EPS
$-9.90
Gross margin
-1.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Rockwell Medical, Inc. (RMTI) Q1 2021 Earnings Call Transcript
Revenue
$15.47M
▼ 2.4% YoY
Diluted EPS
$-9.10
Gross margin
2.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-31
Rockwell Medical, Inc. (RMTI) Q4 2020 Earnings Call Transcript
Revenue
$15.16M*
▼ 2.1% YoY
Gross margin
2.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Rockwell Medical, Inc. (RMTI) Q3 2020 Earnings Call Transcript
Revenue
$15.28M
▼ 0.8% YoY
Diluted EPS
$-11.00
Gross margin
2.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Rockwell Medical, Inc. (RMTI) Q2 2020 Earnings Call Transcript
Revenue
$15.90M
▲ 7.1% YoY
Diluted EPS
$-11.00
Gross margin
5.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Rockwell Medical, Inc. (RMTI) Q1 2020 Earnings Call Transcript
Revenue
$15.86M
▲ 1.9% YoY
Diluted EPS
$-13.20
Gross margin
7.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 webcasts
Key facts CIK 1041024 CUSIP 774374409 13F (30d) 2 filings 2 filers Visit website Investor relations